Skip to content

Regencell Bioscience

US · RGC #2393 by market cap Listed 2021
4.18 -0.18 -4.13%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:34

About Regencell Bioscience

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Founded
2014
CEO
Mr. Yat-Gai Au
Employees
10
Headquarters
Hong Kong,China, HK, China
Fiscal year end
06-30
Website
regencellbioscience.com

Company profile

Exchange
US
Symbol
RGC
Market-cap rank
#2393
Listing date
2021-07-16
Market cap
2.07B
Float cap
235.72M
Shares out
495.88M
Float shares
56.39M

Sectors & themes

Drug Manufacturers - Specialty & Generic Fractional Shares JP Chinese Concept

Browse all sectors & themes

Quote time 2026-11-20 19:34:41 · For reference only, not investment advice and not tailored to your situation.

Regencell Bioscience discussion 0 comments

Add a comment